Interestingly, the authors explain the tumor shrinkage as a result of the balance of the CD8+/Treg ratio, which first requires depletion of Treg capable of causing a reduction in the immunosuppressive effects of IL-10, then promoting the proliferation and differentiation of CD8+ T cells that eliminate cancer cells. The gene discussed is CD8A; the disease is neoplasm.